GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zentiva SA (BSE:SCD) » Definitions » 10-Year ROIIC %

Zentiva (BSE:SCD) 10-Year ROIIC % : 14.52% (As of Dec. 2023)


View and export this data going back to 1998. Start your Free Trial

What is Zentiva 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Zentiva's 10-Year ROIIC % for the quarter that ended in Dec. 2023 was 14.52%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Zentiva's 10-Year ROIIC % or its related term are showing as below:

BSE:SCD's 10-Year ROIIC % is ranked better than
72.64% of 932 companies
in the Drug Manufacturers industry
Industry Median: 3.685 vs BSE:SCD: 14.52

Zentiva 10-Year ROIIC % Historical Data

The historical data trend for Zentiva's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentiva 10-Year ROIIC % Chart

Zentiva Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
10-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.95 4.74 14.31 7.67 14.52

Zentiva Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
10-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 14.52 - - -

Competitive Comparison of Zentiva's 10-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Zentiva's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zentiva's 10-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zentiva's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Zentiva's 10-Year ROIIC % falls into.



Zentiva 10-Year ROIIC % Calculation

Zentiva's 10-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( 177.1722735 (Dec. 2023) - 39.135955 (Dec. 2013) )/( 1212.321 (Dec. 2023) - 261.511 (Dec. 2013) )
=138.0363185/950.81
=14.52%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Zentiva  (BSE:SCD) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Zentiva 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Zentiva's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zentiva Business Description

Traded in Other Exchanges
N/A
Address
No. 50, Theodor Pallady Boulevard, Sector 3, Bucharest, ROU, 032266
Zentiva SA is a Romania-based producer of medicines on the local market. The product portfolio of Zentiva SA includes more than 126 products for human use, such as solids (tablets, capsules, and pellets), generic products, and injectable solutions. The company provides products for therapeutic areas such as Cardiovascular diseases, Anti-inflammatory and pain-relieving medications, urologists, Blood diseases, Gastrointestinal and metabolic disorders, Central nervous system, Medicines against infections, and Diseases of the respiratory system.

Zentiva Headlines

From GuruFocus

LMP Capital and Income Fund Inc. Announces Change in Portfolio Managers

By Business Wire Business Wire 07-26-2022